Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.06−0.17 (-2.73%)
Close on Nov 13, 2026Market cap $492.63MP/E –Yield –
Phathom Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Phathom Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was -9.3%. For fiscal 2025 it was -91.4%, against -502.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -91.4% | +410.8 |
| FY2024 | Dec 31, 2024 | -502.2% | +24030.4 |
| FY2023 | Dec 31, 2023 | -24532.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -0.1% | +30.7 |
| Q2 FY2026 | Jun 30, 2026 | -5.3% | +146.4 |
| Q1 FY2026 | Mar 31, 2026 | -26.5% | +250.0 |
| Q4 FY2025 | Dec 31, 2025 | -10.3% | +190.0 |
| Q3 FY2025 | Sep 30, 2025 | -30.8% | +402.1 |
| Q2 FY2025 | Jun 30, 2025 | -151.7% | +903.7 |
| Q1 FY2025 | Mar 31, 2025 | -276.5% | +3382.2 |
| Q4 FY2024 | Dec 31, 2024 | -200.3% | +10045.3 |
| Q3 FY2024 | Sep 30, 2024 | -433.0% | – |
| Q2 FY2024 | Jun 30, 2024 | -1055.4% | – |
| Q1 FY2024 | Mar 31, 2024 | -3658.7% | – |
| Q4 FY2023 | Dec 31, 2023 | -10245.6% | – |
See a number that looks wrong?